Montauk Metals Inc
MTK
Navco Pharmaceuticals Inc
NAV
MYND Life Sciences Inc
MYND
Consolidated Lithium Metals Inc
CLM
O2Gold Inc
OTGO.H
(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 36.59%833.21K | 33.69%702.76K | 5.58%609.57K | 3.85%610.02K | -1.97%525.67K | 9.32%2.34M | -1.59%642.93K | -5.06%577.37K | 32.41%587.43K | 22.13%536.25K |
Operating revenue | 36.59%833.21K | 33.69%702.76K | 5.58%609.57K | 3.85%610.02K | -1.97%525.67K | 9.32%2.34M | -1.59%642.93K | -5.06%577.37K | 32.41%587.43K | 22.13%536.25K |
Cost of revenue | 21.63%510K | 71.29%492.97K | 7.06%380.74K | 26.28%419.31K | -12.34%287.79K | 38.05%1.45M | 50.73%437.86K | 22.74%355.64K | 43.93%332.04K | 35.58%328.32K |
Gross profit | 69.48%323.21K | -11.81%209.79K | 3.20%228.83K | -25.32%190.71K | 14.40%237.88K | -18.42%890.13K | -43.48%205.07K | -30.36%221.74K | 19.93%255.38K | 5.59%207.94K |
Operating expense | 187.38%566.5K | 55.60%311.94K | 46.58%197.83K | -25.73%197.13K | -28.28%200.48K | -22.14%986.83K | -55.54%306.89K | -26.20%134.96K | 18.91%265.43K | 63.32%279.55K |
Selling and administrative expenses | 118.63%208.19K | -4.30%100.23K | 62.09%148.26K | -36.99%95.23K | -28.87%104.74K | -22.15%616.31K | -57.69%226.46K | 18.63%91.47K | 78.17%151.12K | 55.79%147.26K |
-General and administrative expense | 118.63%208.19K | -4.30%100.23K | 62.09%148.26K | -36.99%95.23K | -28.87%104.74K | -22.15%616.31K | -57.69%226.46K | 18.63%91.47K | 78.17%151.12K | 55.79%147.26K |
Other operating expenses | 251.62%358.3K | 121.13%211.71K | 13.96%49.57K | -10.86%101.9K | -27.63%95.74K | -22.13%370.52K | -48.11%80.42K | -58.88%43.49K | -17.41%114.32K | 72.60%132.29K |
Operating profit | -3,692.49%-243.29K | -373.18%-102.15K | -64.27%31K | 36.16%-6.42K | 152.22%37.39K | 45.17%-96.7K | 68.90%-101.82K | -35.97%86.77K | 2.25%-10.05K | -378.01%-71.61K |
Net non-operating interest income (expenses) | -2,042.96%-2.76K | 101.61%502 | -12.15%188 | -95.90%142 | 102.08%249 | 431.86%24.4K | 33,274.49%32.71K | 365.22%214 | 191.59%3.46K | -222.92%-11.99K |
Non-operating interest income | 33.10%189 | 101.61%502 | -12.15%188 | -95.90%142 | --249 | --24.4K | ---- | 365.22%214 | --3.46K | ---- |
Non-operating interest expense | --2.95K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 222.92%11.99K |
Other net income (expenses) | 3.72%81.09K | -493.14%-130.79K | 56.34%-87.03K | -83.66%78.18K | 135.40%33.27K | 117.03%87.02K | -467.51%-98K | -28.57%-199.35K | 288.68%478.35K | -10.28%-93.98K |
Gain on sale of security | -12.42%81.09K | -493.14%-130.79K | 56.34%-87.03K | 168.23%92.6K | 135.40%33.27K | -18.47%-586.89K | -9,638.00%-157.85K | -28.57%-199.35K | 46.47%-135.71K | -10.28%-93.98K |
Special income (charges) | --0 | --0 | --0 | -102.35%-14.42K | ---- | 4,407.00%673.92K | 482.54%59.86K | --0 | --614.06K | ---- |
-Gain on sale of property,plant,equipment | --0 | --0 | --0 | -102.35%-14.42K | ---- | 4,407.00%673.92K | 482.54%59.86K | --0 | --614.06K | ---- |
Income before tax | -329.39%-164.96K | -427.79%-232.44K | 50.30%-55.84K | -84.76%71.91K | 139.93%70.91K | 102.12%14.71K | 51.50%-167.11K | -476.75%-112.36K | 276.31%471.77K | -181.09%-177.59K |
Income tax | -8.91%115.34K | |||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | -329.39%-164.96K | -427.79%-232.44K | 50.30%-55.84K | -84.76%71.91K | 139.93%70.91K | 87.75%-100.63K | 40.05%-282.45K | -476.75%-112.36K | 276.31%471.77K | -181.09%-177.59K |
Net income continuous operations | -329.39%-164.96K | -427.79%-232.44K | 50.30%-55.84K | -84.76%71.91K | 139.93%70.91K | 87.75%-100.63K | 40.05%-282.45K | -476.75%-112.36K | 276.31%471.77K | -181.09%-177.59K |
Noncontrolling interests | 23.02%66.32K | -25.04%48.92K | 3.51%53.91K | -5.58%63.3K | -2.84%231.13K | -32.64%46.76K | 0.37%65.25K | -3.68%52.08K | 35.73%67.04K | |
Net income attributable to the company | -1,384.93%-231.28K | -3,152.34%-232.44K | 41.02%-104.76K | -95.71%18K | 103.11%7.62K | 68.68%-331.76K | 39.10%-329.21K | -110.21%-177.62K | 230.48%419.69K | -117.31%-244.62K |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -1,384.93%-231.28K | -3,152.34%-232.44K | 41.02%-104.76K | -95.71%18K | 103.11%7.62K | 68.68%-331.76K | 39.10%-329.21K | -110.21%-177.62K | 230.48%419.69K | -117.31%-244.62K |
Diluted earnings per share | -1,211.11%-0.002 | -2,697.40%-0.002 | 50.00%-0.001 | -95.50%0.0002 | 103.85%0.0001 | 72.73%-0.003 | -197.40%-0.003 | -126.50%-0.002 | 218.80%0.004 | -67.79%-0.002 |
Basic earnings per share | -1,211.11%-0.002 | -2,697.40%-0.002 | 50.00%-0.001 | -95.50%0.0002 | 103.85%0.0001 | 72.73%-0.003 | -197.40%-0.003 | -126.50%-0.002 | 218.80%0.004 | -67.79%-0.002 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.